Your browser doesn't support javascript.
loading
Measuring waning protection from seasonal influenza vaccination during nine influenza seasons, Ontario, Canada, 2010/11 to 2018/19.
Chung, Hannah; Campitelli, Michael A; Buchan, Sarah A; Campigotto, Aaron; Crowcroft, Natasha S; Gubbay, Jonathan B; Jung, James Kh; Karnauchow, Timothy; Katz, Kevin; McGeer, Allison J; McNally, J Dayre; Richardson, David C; Richardson, Susan E; Rosella, Laura C; Russell, Margaret L; Schwartz, Kevin L; Simor, Andrew; Smieja, Marek; Sundaram, Maria E; Warshawsky, Bryna F; Zahariadis, George; Kwong, Jeffrey C.
Affiliation
  • Chung H; ICES, Toronto, Canada.
  • Campitelli MA; ICES, Toronto, Canada.
  • Buchan SA; Public Health Ontario, Toronto, Canada.
  • Campigotto A; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
  • Crowcroft NS; ICES, Toronto, Canada.
  • Gubbay JB; London Health Sciences Centre, London, Canada.
  • Jung JK; Hospital for Sick Children, Toronto, Canada.
  • Karnauchow T; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
  • Katz K; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Canada.
  • McGeer AJ; Public Health Ontario, Toronto, Canada.
  • McNally JD; ICES, Toronto, Canada.
  • Richardson DC; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
  • Richardson SE; Hospital for Sick Children, Toronto, Canada.
  • Rosella LC; Public Health Ontario, Toronto, Canada.
  • Russell ML; ICES, Toronto, Canada.
  • Schwartz KL; Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada.
  • Simor A; Children's Hospital of Eastern Ontario, Ottawa, Canada.
  • Smieja M; North York General Hospital, Toronto, Canada.
  • Sundaram ME; Sinai Health System, Toronto, Canada.
  • Warshawsky BF; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
  • Zahariadis G; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
  • Kwong JC; Children's Hospital of Eastern Ontario, Ottawa, Canada.
Euro Surveill ; 29(8)2024 Feb.
Article in En | MEDLINE | ID: mdl-38390652
ABSTRACT
BackgroundWaning immunity from seasonal influenza vaccination can cause suboptimal protection during peak influenza activity. However, vaccine effectiveness studies assessing waning immunity using vaccinated and unvaccinated individuals are subject to biases.AimWe examined the association between time since vaccination and laboratory-confirmed influenza to assess the change in influenza vaccine protection over time.MethodsUsing linked laboratory and health administrative databases in Ontario, Canada, we identified community-dwelling individuals aged ≥ 6 months who received an influenza vaccine before being tested for influenza by RT-PCR during the 2010/11 to 2018/19 influenza seasons. We estimated the adjusted odds ratio (aOR) for laboratory-confirmed influenza by time since vaccination (categorised into intervals) and for every 28 days.ResultsThere were 53,065 individuals who were vaccinated before testing for influenza, with 10,264 (19%) influenza-positive cases. The odds of influenza increased from 1.05 (95% CI 0.91-1.22) at 42-69 days after vaccination and peaked at 1.27 (95% CI 1.04-1.55) at 126-153 days when compared with the reference interval (14-41 days). This corresponded to 1.09-times increased odds of influenza every 28 days (aOR = 1.09; 95% CI 1.04-1.15). Individuals aged 18-64 years showed the greatest decline in protection against influenza A(H1N1) (aORper 28 days = 1.26; 95% CI 0.97-1.64), whereas for individuals aged ≥ 65 years, it was against influenza A(H3N2) (aORper 28 days = 1.20; 95% CI 1.08-1.33). We did not observe evidence of waning vaccine protection for individuals aged < 18 years.ConclusionsInfluenza vaccine protection wanes during an influenza season. Understanding the optimal timing of vaccination could ensure robust protection during seasonal influenza activity.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / Influenza A Virus, H1N1 Subtype Limits: Humans Country/Region as subject: America do norte Language: En Journal: Euro Surveill Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Type: Article Affiliation country: Canada

Full text: 1 Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / Influenza A Virus, H1N1 Subtype Limits: Humans Country/Region as subject: America do norte Language: En Journal: Euro Surveill Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Type: Article Affiliation country: Canada